India Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

Description

List of Tables

GlobalData's "India Oncology Market Outlook to 2033" is a comprehensive databook report, covering key market data on the India Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests, ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests

The India Oncology Market report provides key information and data on -

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2024 company share data for Oncology Market.
Global corporate-level profiles of key companies operating within the India Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

India Oncology is segmented as follows -

Colorectal Cancer Screening Tests
EGFR Tests
KRAS Tests
HER2 Tests
BRCA Tests
ALK Tests
BRAF Tests
BCR-ABL Tests
PD-L1 Tests

Reasons to Buy

The India Oncology Market report helps you to develop -

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Product Code: GDME25618CCDB

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Oncology Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Oncology Market, India

3.1 Oncology Market, India, Revenue ($m), 2018-2033
- 3.1.1 ALK Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.1.2 BCR-ABL Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.1.3 BRAF Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.1.4 BRCA Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.1.5 Colorectal Cancer Screening Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.1.6 EGFR Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.1.7 HER2 Tests Market, India, Revenue ($m), by Segment, 2018-2033
- 3.1.8 KRAS Tests Market, India, Revenue ($m), by Segment, 2018-2033
3.2 Oncology Market, India, Volume (Units), 2018-2033
- 3.2.1 ALK Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.2.2 BCR-ABL Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.2.3 BRAF Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.2.4 BRCA Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.2.5 Colorectal Cancer Screening Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.2.6 EGFR Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.2.7 HER2 Tests Market, India, Volume (Units), by Segment, 2018-2033
- 3.2.8 KRAS Tests Market, India, Volume (Units), by Segment, 2018-2033
3.3 Oncology Market, India, Average Price ($) , 2018-2033
3.4 Oncology Market, India, Company Share by Revenue ($m), 2024

4 Overview of Key Companies in India, Oncology Market

4.1 F. Hoffmann-La Roche Ltd
- 4.1.1 Company Overview
4.2 BioGenex Laboratories Inc
- 4.2.1 Company Overview
4.3 Agilent Technologies Inc
- 4.3.1 Company Overview
4.4 Danaher Corp
- 4.4.1 Company Overview
4.5 Eiken Chemical Co Ltd
- 4.5.1 Company Overview
4.6 Hemosure Inc
- 4.6.1 Company Overview
4.7 Quidelortho Corp
- 4.7.1 Company Overview
4.8 Qiagen NV
- 4.8.1 Company Overview
4.9 Bio-Techne Corp
- 4.9.1 Company Overview

5 Oncology Market Pipeline Products

6 Financial Deals Landscape

6.1 Venture Financing
- 6.1.1 Oncare Secures USD1 Million in Seed Funding
- 6.1.2 Cambrian Bioworks Secures USD1.45 Million in Seed Financing
- 6.1.3 4baseCare Raises USD5.95 Million in Series A Funding

7 Recent Developments

7.1 Other Significant Developments
- 7.1.1 Sep 11, 2024: Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Awardees, Including First Recipients in India and the Netherlands
- 7.1.2 Jul 25, 2024: Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
7.2 Product News
- 7.2.1 Jan 28, 2025: Datar Cancer Genetics To Provide Groundbreaking Video-Enhanced Results of In-Vitro Chemotherapy Effectiveness Tests for Cancer Patients
- 7.2.2 Jan 23, 2025: Guardant Health To Present Data at ASCO GI Demonstrating the Value of Its Precision Oncology Tools for Cancer Detection, Treatment Decisions and Therapy Development
- 7.2.3 Jul 30, 2024: Biocon Foundation and IISc organize OCTF Conference on Artificial Intelligence in Oral Cancer
- 7.2.4 Jul 15, 2024: Peptomyc S.L. Expands Patent Portfolio with European and Indian Patent Grant for its Methods and Composition for the Treatment of Cancer
7.3 Strategy And Business Planning
- 7.3.1 Oct 29, 2024: American Oncology Network (AON) and Vantage Health Technologies Partner to Improve Cancer Patient Outcomes with AI-enabled Value-Based Care Platform
- 7.3.2 Jul 01, 2024: NURA Health Screening Center Opens in Hanoi, Vietnam

8 Appendix

8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer

Product Code: GDME25618CCDB

List of Table

List of Tables

Table 1: Oncology Market, India, Revenue ($m), USD Constant, 2018-2033
Table 2: ALK Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Table 3: BCR-ABL Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Table 4: BRAF Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Table 5: BRCA Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Table 6: Colorectal Cancer Screening Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Table 7: EGFR Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Table 8: HER2 Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Table 9: KRAS Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Table 10: Oncology Market, India, Volume (Units), 2018-2033
Table 11: ALK Tests Market, India, Volume (Units), 2018-2033
Table 12: BCR-ABL Tests Market, India, Volume (Units), 2018-2033
Table 13: BRAF Tests Market, India, Volume (Units), 2018-2033
Table 14: BRCA Tests Market, India, Volume (Units), 2018-2033
Table 15: Colorectal Cancer Screening Tests Market, India, Volume (Units), 2018-2033
Table 16: EGFR Tests Market, India, Volume (Units), 2018-2033
Table 17: HER2 Tests Market, India, Volume (Units), 2018-2033
Table 18: KRAS Tests Market, India, Volume (Units), 2018-2033
Table 19: Oncology Market, India, Average Price ($), 2018-2033
Table 20: Oncology Market, India, Company Share by Revenue ($m), 2024
Table 21: Oncology Market Pipeline Products
Table 22: Oncare Secures USD1 Million in Seed Funding
Table 23: Cambrian Bioworks Secures USD1.45 Million in Seed Financing
Table 24: 4baseCare Raises USD5.95 Million in Series A Funding
Table 25: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

List of Figure

List of Figures

Figure 1: Oncology Market, India, Revenue ($m), USD Constant, 2018-2033
Figure 2: ALK Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Figure 3: BCR-ABL Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Figure 4: BRAF Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Figure 5: BRCA Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Figure 6: Colorectal Cancer Screening Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Figure 7: EGFR Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Figure 8: HER2 Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Figure 9: KRAS Tests Market, India, Revenue ($m), USD Constant, 2018-2033
Figure 10: Oncology Market, India, Volume (Units), 2018-2033
Figure 11: ALK Tests Market, India, Volume (Units), 2018-2033
Figure 12: BCR-ABL Tests Market, India, Volume (Units), 2018-2033
Figure 13: BRAF Tests Market, India, Volume (Units), 2018-2033
Figure 14: BRCA Tests Market, India, Volume (Units), 2018-2033
Figure 15: Colorectal Cancer Screening Tests Market, India, Volume (Units), 2018-2033
Figure 16: EGFR Tests Market, India, Volume (Units), 2018-2033
Figure 17: HER2 Tests Market, India, Volume (Units), 2018-2033
Figure 18: KRAS Tests Market, India, Volume (Units), 2018-2033
Figure 19: Oncology Market, India, Company Share (%), 2024